Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer

J Endocrinol Invest. 2021 Dec;44(12):2859. doi: 10.1007/s40618-021-01592-7.

¹ Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Via Paradisa 2, 56124, Pisa, Italy.
² Department of Oncology, Oncological Endocrinology Unit, Azienda Ospedaliero Universitaria Città Della Salute E Della Scienza Di Torino, Corso Bramante, 88, 10126, Turin, Italy.
³ Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Via Paradisa 2, 56124, Pisa, Italy. rossella.elisei@med.unipi.it.

^# Contributed equally.

No abstract available

Publication types